Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

Roche (RHHBY) has hired a senior executive from Novo Nordisk (NVO) as it prepares to enter the competitive market for obesity drugs, Bloomberg’s Naomi Kresge and Sara Sjolin report. Morten ...

Genentech, a member of the Roche (RHHBY) Group, announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health-sponsored Phase III OUtMATCH study, which provide further ...

This study published in the journal Nature highlights the potential of artificial molecular motors to explain one of the great principles of how living systems work. It could also inspire the design ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems ... This review examines key molecular applications in diagnosing and ...

molecular substances are first to be designed computationally and subsequently evaluated in biological systems with differing complexity, ranging from in-vitro assays via experiments with cell ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...